leisure time -WSS

leisure time

author：entertainment 2025-09-03 15:17:19 - browse：2169

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Illumina slashes 2023 revenue projections yet again

focus

leisure time

WSS

Readout LOUD podcast: How biotech is using artificial intelligence

PhRMA lawsuit over Medicare drug price negotiation tossed

Biden administration begins canceling student loan debt for 804,000 borrowers

Surge in Apellis stock fueled by confidence in safety of its eye drug

Private equity deals in Medicare Advantage declines

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

hotspot

leisure time

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Wildfire smoke exposes gaps in outdoor worker protections

Schizophrenia gene found to be linked to cells' energy dysfunction

Walensky prepares to leave CDC — and Congress — behind

Idaho college killings prosecutors challenge defense's grand jury claims

Peter Hotez and the public health issue of online harassment

'Revelatory' study finds a smoking impact that remains after quitting

Hollywood unions extend contract negotiations for actors

For Medicare Advantage, Democrats want stronger protections around AI

focus

Schizophrenia gene found to be linked to cells' energy dysfunction

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Be careful with at

Illinois Supreme Court finds assault weapons ban constitutional

Illumina slashes 2023 revenue projections yet again

knowledge

focus

leisure time

explore